Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Noncoding RNA Profiles in Tobacco- and Alcohol-Associated Diseases.

Soares do Amaral N, Cruz E Melo N, de Melo Maia B, Malagoli Rocha R.

Genes (Basel). 2016 Dec 23;8(1). pii: E6. doi: 10.3390/genes8010006. Review.

2.

MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression.

de Melo Maia B, Rodrigues IS, Akagi EM, Soares do Amaral N, Ling H, Monroig P, Soares FA, Calin GA, Rocha RM.

Oncotarget. 2016 Aug 2;7(31):49217-49231. doi: 10.18632/oncotarget.10247.

3.

An Integrative Approach Uncovers Biomarkers that Associate with Clinically Relevant Disease Outcomes in Vulvar Carcinoma.

Lavorato-Rocha AM, Akagi EM, de Melo Maia B, Rodrigues IS, Botelho MC, Marchi FA, Fernandes G, Baiocchi G, Soares FA, Rogatto SR, Sato-Kuwabara Y, Rocha RM.

Mol Cancer Res. 2016 Aug;14(8):720-9. doi: 10.1158/1541-7786.MCR-15-0366. Epub 2016 May 11.

4.

Design of a miRNA sponge for the miR-17 miRNA family as a therapeutic strategy against vulvar carcinoma.

de Melo Maia B, Ling H, Monroig P, Ciccone M, Soares FA, Calin GA, Rocha RM.

Mol Cell Probes. 2015 Dec;29(6):420-426. doi: 10.1016/j.mcp.2015.08.002. Epub 2015 Aug 20.

PMID:
26297962
5.

ROCK1 as a novel prognostic marker in vulvar cancer.

Akagi EM, Lavorato-Rocha AM, Maia Bde M, Rodrigues IS, Carvalho KC, Stiepcich MM, Baiocchi G, Sato-Kuwabara Y, Rogatto SR, Soares FA, Rocha RM.

BMC Cancer. 2014 Nov 7;14:822. doi: 10.1186/1471-2407-14-822.

6.

EGFR expression in vulvar cancer: clinical implications and tumor heterogeneity.

de Melo Maia B, Fontes AM, Lavorato-Rocha AM, Rodrigues IS, de Brot L, Baiocchi G, Stiepcich MM, Soares FA, Rocha RM.

Hum Pathol. 2014 May;45(5):917-25. doi: 10.1016/j.humpath.2014.01.015. Epub 2014 Jan 31.

PMID:
24746196
7.

microRNA portraits in human vulvar carcinoma.

de Melo Maia B, Lavorato-Rocha AM, Rodrigues LS, Coutinho-Camillo CM, Baiocchi G, Stiepcich MM, Puga R, de A Lima L, Soares FA, Rocha RM.

Cancer Prev Res (Phila). 2013 Nov;6(11):1231-41. doi: 10.1158/1940-6207.CAPR-13-0121. Epub 2013 Sep 18.

8.

Cell cycle suppressor proteins are not related to HPV status or clinical outcome in patients with vulvar carcinoma.

Lavorato-Rocha AM, Rodrigues IS, de Melo Maia B, Stiepcich MM, Baiocchi G, Carvalho KC, Soares FA, Vassallo J, Rocha RM.

Tumour Biol. 2013 Dec;34(6):3713-20. doi: 10.1007/s13277-013-0955-0. Epub 2013 Jul 6.

PMID:
23832541
9.

Characterization of sociodemographic and clinicopathological features in Brazilian patients with vulvar squamous cell carcinoma.

de Melo Maia B, Munhoz Cestari F, Lavorato-Rocha AM, Sant'Ana Rodrigues I, Baiocchi G, Cardoso GuimarĂ£es G, Vassallo J, Stiepcich M, Soares FA, Malagoli Rocha R.

Gynecol Obstet Invest. 2013;75(1):53-60. doi: 10.1159/000343758. Epub 2012 Dec 7.

PMID:
23235299
10.

Prognostication of vulvar cancer based on p14ARF status: molecular assessment of transcript and protein.

Lavorato-Rocha AM, de Melo Maia B, Rodrigues IS, Stiepcich MM, Baiocchi G, da Silva Cestari FM, Carvalho KC, Soares FA, Rocha RM.

Ann Surg Oncol. 2013 Jan;20(1):31-9. doi: 10.1245/s10434-012-2560-7. Epub 2012 Aug 10.

PMID:
22878614
11.

Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside.

de Melo Maia B, Lavorato-Rocha AM, Rodrigues IS, Baiocchi G, Cestari FM, Stiepcich MM, Chinen LT, Carvalho KC, Soares FA, Rocha RM.

J Transl Med. 2012 Jul 28;10:150. doi: 10.1186/1479-5876-10-150.

Supplemental Content

Loading ...
Support Center